Search our
Current Studies

Still have some questions about the process? Review our Frequently Asked Questions for the answers.
Learn More
Image

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN FORTE)

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Diabetes

A Phase II Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Study to Evaluate the Safety and Efficacy of Repeated Oral Doses of Blautix in Adult Subjects With Irritable Bowel Syndrome (IBS) Subtypes IBS-C and IBS-D

Location(s):

Condition:

The study will explore the effects of three different InterStim amplitude settings on overactive bladder symptoms (OAB).

Location(s): Jacksonville (Headquarters)

Condition: Urology

A Randomized, Phase 3, Open-Label Trial Comparing the Effect of Tirzepatide Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): St. Augustine

Condition: Cholesterol, Heart Disease

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

Location(s): Jacksonville (Headquarters)

Condition: Diabetes

A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown)

Condition: Kidney Disease

A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)

Location(s): Jacksonville (Headquarters)

Condition: Heart Failure

Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)

Location(s): Jacksonville (Headquarters)

Condition: Diabetes, Heart Disease, Kidney Disease

The purpose of the study is to collect data about how well U-100 Regular Human Insulin can be used in the V-Go Insulin Delivery Device compared to U-100 Rapid Acting Insulin in the V-Go Insulin Delivery Device. The data collected will be used to see how much subjects’ blood sugar levels change over time after they switch from using U-100 Rapid Acting Insulin to U-100 Regular Human Insulin within their V-Go Insulin Delivery Device.

Location(s): Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Diabetes, Kidney Disease

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Diabetes, Kidney Disease

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Location(s): Jacksonville (Headquarters)

Condition: Heart Disease, Heart Failure